Upgrade to SI Premium - Free Trial

Morgan Stanley stays Overweight on Johnson & Johnson (JNJ) following 'expected positive' Ico approval

March 18, 2026 11:23 AM
Morgan Stanley analyst Terrance Flynn reiterated an Overweight rating and $262.00 price target on Johnson & Johnson (NYSE: JNJ)The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments